Sandoz Opens Up The Market For Its US Remodulin Rival

Subcutaneous Version Of Treprostinil Approved For Existing Device More Than Doubles Opportunity

 
• By Dave Wallace
  
Alternative Route
Sandoz’ treprostinil is now available via a new route of administration • Source: Alamy

More from Generics

More from Products